379 related articles for article (PubMed ID: 28596377)
41. Chimeric Fc receptors identify ligand binding regions in human glycoprotein VI.
Dumont B; Minullina I; Loyau S; Monteiro RC; Lacapere JJ; Arocas V; Jandrot-Perrus M
J Mol Biol; 2006 Sep; 361(5):877-87. PubMed ID: 16876821
[TBL] [Abstract][Full Text] [Related]
42. Galectin-9 activates platelet ITAM receptors glycoprotein VI and C-type lectin-like receptor-2.
Zhi Z; Jooss NJ; Sun Y; Colicchia M; Slater A; Moran LA; Cheung HYF; Di Y; Rayes J; Poulter NS; Watson SP; Iqbal AJ
J Thromb Haemost; 2022 Apr; 20(4):936-950. PubMed ID: 34936188
[TBL] [Abstract][Full Text] [Related]
43. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?
Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L
Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951
[TBL] [Abstract][Full Text] [Related]
44. Crotavirin, a potent platelet aggregation inhibitor purified from the venom of the snake Crotalus viridis.
Liu CZ; Peng HC; Huang TF
Toxicon; 1995 Oct; 33(10):1289-98. PubMed ID: 8599180
[TBL] [Abstract][Full Text] [Related]
45. The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion.
Chen H; Locke D; Liu Y; Liu C; Kahn ML
J Biol Chem; 2002 Jan; 277(4):3011-9. PubMed ID: 11723134
[TBL] [Abstract][Full Text] [Related]
46. Towards the Therapeutic Use of Thrombospondin 1/CD47 Targeting TAX2 Peptide as an Antithrombotic Agent.
Jeanne A; Sarazin T; Charlé M; Kawecki C; Kauskot A; Hedtke T; Schmelzer CEH; Martiny L; Maurice P; Dedieu S
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e1-e17. PubMed ID: 33232198
[TBL] [Abstract][Full Text] [Related]
47. Crotalin, a vWF and GP Ib cleaving metalloproteinase from venom of Crotalus atrox.
Wu WB; Peng HC; Huang TF
Thromb Haemost; 2001 Dec; 86(6):1501-11. PubMed ID: 11776320
[TBL] [Abstract][Full Text] [Related]
48. Bilinexin, a snake C-type lectin from Agkistrodon bilineatus venom agglutinates platelets via GPIb and alpha2beta1.
Du XY; Navdaev A; Clemetson JM; Magnenat E; Wells TN; Clemetson KJ
Thromb Haemost; 2001 Nov; 86(5):1277-83. PubMed ID: 11816718
[TBL] [Abstract][Full Text] [Related]
49. Characterization of a patient with glycoprotein (GP) VI deficiency possessing neither anti-GPVI autoantibody nor genetic aberration.
Kojima H; Moroi M; Jung SM; Goto S; Tamura N; Kozuma Y; Suzukawa K; Nagasawa T
J Thromb Haemost; 2006 Nov; 4(11):2433-42. PubMed ID: 17059472
[TBL] [Abstract][Full Text] [Related]
50. Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo.
Kuijpers MJ; Schulte V; Bergmeier W; Lindhout T; Brakebusch C; Offermanns S; Fässler R; Heemskerk JW; Nieswandt B
FASEB J; 2003 Apr; 17(6):685-7. PubMed ID: 12586747
[TBL] [Abstract][Full Text] [Related]
51. Identification of residues within human glycoprotein VI involved in the binding to collagen: evidence for the existence of distinct binding sites.
Lecut C; Arocas V; Ulrichts H; Elbaz A; Villeval JL; Lacapère JJ; Deckmyn H; Jandrot-Perrus M
J Biol Chem; 2004 Dec; 279(50):52293-9. PubMed ID: 15466473
[TBL] [Abstract][Full Text] [Related]
52. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
[TBL] [Abstract][Full Text] [Related]
53. A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist.
Wang WJ; Huang TF
Thromb Haemost; 2001 Oct; 86(4):1077-86. PubMed ID: 11686327
[TBL] [Abstract][Full Text] [Related]
54. Characterization of GPVI- or GPVI-CD39-Coated Nanoparticles and Their Impact on In Vitro Thrombus Formation.
Nestele JA; Rohlfing AK; Dicenta V; Bild A; Eißler D; Emschermann F; Kremser M; Krutzke K; Schäffer TE; Borst O; Levi M; Korin N; Gawaz MP
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008437
[TBL] [Abstract][Full Text] [Related]
55. Signal transduction pathways mediated by glycoprotein Ia/IIa in human platelets: comparison with those of glycoprotein VI.
Inoue K; Ozaki Y; Satoh K; Wu Y; Yatomi Y; Shin Y; Morita T
Biochem Biophys Res Commun; 1999 Mar; 256(1):114-20. PubMed ID: 10066433
[TBL] [Abstract][Full Text] [Related]
56. A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.
Hermans C; Wittevrongel C; Thys C; Smethurst PA; Van Geet C; Freson K
J Thromb Haemost; 2009 Aug; 7(8):1356-63. PubMed ID: 19552682
[TBL] [Abstract][Full Text] [Related]
57. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions.
Oostingh GJ; Pozgajova M; Ludwig RJ; Krahn T; Boehncke WH; Nieswandt B; Schön MP
Haematologica; 2007 Apr; 92(4):502-12. PubMed ID: 17488661
[TBL] [Abstract][Full Text] [Related]
58. Crotacetin, a novel snake venom C-type lectin homolog of convulxin, exhibits an unpredictable antimicrobial activity.
Rádis-Baptista G; Moreno FB; de Lima Nogueira L; Martins AM; de Oliveira Toyama D; Toyama MH; Cavada BS; de Azevedo WF; Yamane T
Cell Biochem Biophys; 2006; 44(3):412-23. PubMed ID: 16679528
[TBL] [Abstract][Full Text] [Related]
59. Glycoprotein VI-mediated platelet fibrinogen receptor activation occurs through calcium-sensitive and PKC-sensitive pathways without a requirement for secreted ADP.
Quinton TM; Ozdener F; Dangelmaier C; Daniel JL; Kunapuli SP
Blood; 2002 May; 99(9):3228-34. PubMed ID: 11964287
[TBL] [Abstract][Full Text] [Related]
60. Triflavin, an Arg-Gly-Asp containing snake venom peptide, inhibits aggregation of human platelets induced by human hepatoma cell line.
Sheu JR; Lin CH; Chung JL; Teng CM; Huang TF
Thromb Res; 1992 Jun; 66(6):679-91. PubMed ID: 1519227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
